Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» bladder cancer
bladder cancer
Bristol Myers, overshadowed by ADC rival, wins FDA nod for Opdivo combo in bladder cancer
Fierce Pharma
Fri, 03/8/24 - 11:54 am
Bristol Myers Squibb
Opdivo
FDA
bladder cancer
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
oncology
clinical trials
Daiichi Sankyo
AstraZeneca
Enhertu
metastatic breast cancer
Gilead Sciences
Trodelvy
bladder cancer
GSK
Zejula
Jemperli
ovarian cancer
Roche
tiragolumab
Tecentriq
non-small cell lung cancer
Cue Biopharma
CUE-101
head and neck cancer
Elicio Therapeutics
ELI-002
solid tumors
Ferring’s microbiome and gene therapy firsts take the company beyond reproductive health
Pharma Voice
Thu, 02/22/24 - 11:45 am
Ferring Pharmaceuticals
gene therapy
microbiome
bladder cancer
C. difficile
After Padcev combo’s major triumph, Merck’s Keytruda delivers partial win in bladder cancer
Fierce Pharma
Fri, 01/26/24 - 12:03 pm
Merck
Keytruda
bladder cancer
Johnson & Johnson wins full FDA approval for bladder cancer therapy Balversa
Seeking Alpha
Sun, 01/21/24 - 05:11 pm
JNJ
bladder cancer
Balversa
erdafitinib
urothelial cancer
CG Oncology aims for $209M IPO, as more biotechs eye path to public markets
Fierce Biotech
Thu, 01/18/24 - 11:11 am
CG Oncology
IPOs
oncology
bladder cancer
CG Oncology plans IPO plunge ahead of phase 3 bladder cancer drug readout
Fierce Biotech
Wed, 01/3/24 - 09:35 am
CG Oncology
IPOs
bladder cancer
Merck, Astellas and Pfizer bring down the house with Keytruda-Padcev FDA nod in bladder cancer
Fierce Pharma
Tue, 12/19/23 - 10:26 am
Merck
Astellas
Pfizer
Keytruda
Padcev
bladder cancer
BMS chases Merck/Seagen with first-line bladder cancer filing
Pharmaphorum
Tue, 12/5/23 - 11:53 pm
Bristol Myers Squibb
Opdivo
bladder cancer
urothelial cancer
Merck
Seagen
FDA starts review of Padcev/Keytruda for bladder cancer
Pharmaphorum
Fri, 12/1/23 - 09:35 am
Merck
Astellas
Seagen
Padcev
bladder cancer
FDA
priority review
Merck, BMS Score Separate Late-Stage Victories in Bladder Cancer at ESMO
BioSpace
Mon, 10/23/23 - 05:15 pm
ESMO
Merck
Bristol Myers Squibb
bladder cancer
PD-1 inhibitors
Keytruda
Padcev
Opdivo
ESMO: Bristol Myers' Opdivo chalks up bladder cancer win. But a rival combo casts long shadow
Fierce Pharma
Sun, 10/22/23 - 06:06 pm
ESMO
Bristol Myers Squibb
Opdivo
bladder cancer
Padcev
Keytruda
Merck
ESMO: Seagen, Astellas and Merck knock it out of the park with Padcev-Keytruda combo in bladder cancer
Fierce Pharma
Wed, 10/18/23 - 11:42 am
Seagen
Astellas
Merck
Padcev
Keytruda
bladder cancer
ESMO
Merck eyes new bladder cancer space with positive Keytruda trial in muscle-invasive disease
Fierce Pharma
Thu, 10/5/23 - 09:03 pm
Merck
Keytruda
bladder cancer
muscle-invasive urothelial carcinoma
Merck, Seagen and Astellas Get Late-Stage Win in Bladder Cancer with Combo
BioSpace
Fri, 09/22/23 - 11:53 am
Merck
Seagen
Astellas
urothelial cancer
clinical trials
bladder cancer
Padcev
Keytruda
Royalty Pharma to Pay Potential $500M for Royalties on Ferring’s Gene Therapy
BioSpace
Thu, 08/24/23 - 08:34 pm
Ferring Pharmaceuticals
Royalty Pharma
gene therapy
bladder cancer
CG brings back the crossover round, reeling in $105M to fund phase 3 bladder cancer trial
Fierce Biotech
Wed, 08/2/23 - 11:30 am
CG Oncology
funding
bladder cancer
clinical trials
Urogen's Potential First Non-Surgical Therapy for LG-IR-NMIBC Posts Promising Phase 3 Trial Data
Benzinga
Thu, 07/27/23 - 11:35 am
Urogen
clinical trials
UGN-102
non-muscle invasive bladder cancer
bladder cancer
Bristol Myers' Opdivo stages comeback in bladder cancer, teeing up 2 'Merck' showdowns
Fierce Pharma
Wed, 07/12/23 - 09:30 am
Bristol Myers Squibb
Opdivo
bladder cancer
Merck
Ferring, with manufacturing update, takes a step towards first gene therapy sales
BioPharma Dive
Wed, 06/14/23 - 10:07 am
Ferring Pharmaceuticals
FDA
bladder cancer
gene therapy
Adstiladrin
Pages
1
2
3
4
5
6
7
8
next ›
last »